{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-008824","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.756729+00:00","generated_at":"2026-06-05T03:27:41.211003+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MyMD Pharmaceuticals regains Nasdaq minimum bid price compliance after reverse stock split","bullets":["Received notice from Nasdaq on March 4, 2024 that it has regained compliance with Listing Rule 5550(a)(2).","Deficiency flagged Oct 11, 2023 after shares failed to maintain $1.00 bid for 30 consecutive days.","Conducted a 1-for-30 reverse stock split on Feb 14, 2024; split-adjusted trading began Feb 15.","Minimum bid price of $1.00 maintained for 10 consecutive business days, requirement met on March 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-008824","json":"https://secwatch.observer/filing/0001493152-24-008824.json","markdown":"https://secwatch.observer/filing/0001493152-24-008824.md","text":"https://secwatch.observer/filing/0001493152-24-008824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/0001493152-24-008824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:27:41.211003+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}